Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity


Treatment with therapeutic proteins is an attractive approach to targeting a number of challenging diseases. Unfortunately, the native proteins themselves are often unstable in physiological conditions, reducing bioavailability and therefore increasing the dose that is required. Conjugation with poly(ethylene glycol) (PEG) is often used to increase stability, but this has a detrimental effect on bioactivity. Here, we introduce conjugation with zwitterionic polymers such as poly(carboxybetaine). We show that poly(carboxybetaine) conjugation improves stability in a manner similar to PEGylation, but that the new conjugates retain or even improve the binding affinity as a result of enhanced protein–substrate hydrophobic interactions. This chemistry opens a new avenue for the development of protein therapeutics by avoiding the need to compromise between stability and affinity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Stability of PEG, pCB Mn (similar molecular weight) and pCB Rh (similar hydrodynamic size) conjugated with enzyme CT.
Figure 2: Affinities of prepared conjugates measured as Michaelis constants Km.
Figure 3: Mechanism of how PEG and pCB polymers influence binding affinity.

Similar content being viewed by others


  1. Harris, J. M. & Chess, R. B. Effect of pegylation on pharmaceuticals. Nature Rev. Drug Discov. 2, 214–221 (2003).

    Article  CAS  Google Scholar 

  2. Jevsevar, S., Kunstelj, M. & Porekar, V. G. PEGylation of therapeutic proteins. Biotechnol. J. 5, 113–128 (2010).

    Article  CAS  Google Scholar 

  3. Fishburn, C. S. The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics. J. Pharm. Sci. 97, 4167–4183 (2008).

    Article  CAS  Google Scholar 

  4. Veronese, F. M. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 22, 405–417 (2001).

    Article  CAS  Google Scholar 

  5. Shaunak, S. et al. Site-specific PEGylation of native disulfide bonds in therapeutic proteins. Nature Chem. Biol. 2, 312–313 (2006).

    Article  CAS  Google Scholar 

  6. Veronese, F. M. & Mero, A. The impact of PEGylation on biological therapies. Biodrugs 22, 315–329 (2008).

    Article  CAS  Google Scholar 

  7. Chapman, A. P. PEGylated antibodies and antibody fragments for improved therapy: a review. Adv. Drug Deliv. Rev. 54, 531–545 (2002).

    Article  CAS  Google Scholar 

  8. Rodriguez-Martinez, J. A., Rivera-Rivera, I., Sola, R. J. & Griebenow, K. Enzymatic activity and thermal stability of PEG-alpha-chymotrypsin conjugates. Biotechnol. Lett. 31, 883–887 (2009).

    Article  CAS  Google Scholar 

  9. Jiang, S. Y. & Cao, Z. Q. Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications. Adv. Mater. 22, 920–932 (2010).

    Article  CAS  Google Scholar 

  10. Yang, W., Zhang, L., Wang, S. L., White, A. D. & Jiang, S. Y. Functionalizable and ultra stable nanoparticles coated with zwitterionic poly(carboxybetaine) in undiluted blood serum. Biomaterials 30, 5617–5621 (2009).

    Article  CAS  Google Scholar 

  11. Gref, R. et al. Biodegradable long-circulating polymeric nanospheres. Science 263, 1600–1603 (1994).

    Article  CAS  Google Scholar 

  12. Prime, K. L. & Whitesides, G. M. Self-assembled organic monolayers—model systems for studying adsorption of proteins at surfaces. Science 252, 1164–1167 (1991).

    Article  CAS  Google Scholar 

  13. Szleifer, I. Polymers and proteins: interactions at interfaces. Curr. Opin. Solid State Mater. Sci. 2, 337–344 (1997).

    Article  CAS  Google Scholar 

  14. Kane, R. S., Deschatelets, P. & Whitesides, G. M. Kosmotropes form the basis of protein-resistant surfaces. Langmuir 19, 2388–2391 (2003).

    Article  CAS  Google Scholar 

  15. Cacace, M. G., Landau, E. M. & Ramsden, J. J. The Hofmeister series: salt and solvent effects on interfacial phenomena. Q. Rev. Biophys. 30, 241–277 (1997).

    Article  CAS  Google Scholar 

  16. Georgiev, G. S. et al. Self-assembly, anti polyelectrolyte effect, and nonbiofouling properties of polyzwitterions. Biomacromolecules 7, 1329–1334 (2006).

    Article  CAS  Google Scholar 

  17. Treethammathurot, B., Ovartlarnporn, C., Wungsintaweekul, J., Duncan, R. & Wiwattanapatapee, R. Effect of PEG molecular weight and linking chemistry on the biological activity and thermal stability of PEGylated trypsin. Int. J. Pharm. 357, 252–259 (2008).

    Article  Google Scholar 

  18. Rodriguez-Martinez, J. A. et al. Stabilization of alpha-chymotrypsin upon PEGylation correlates with reduced structural dynamics. Biotechnol. Bioeng. 101, 1142–1149 (2008).

    Article  CAS  Google Scholar 

  19. Pegram, L. M. & Record, M. T. Hofmeister salt effects on surface tension arise from partitioning of anions and cations between bulk water and the air–water interface. J. Phys. Chem. B 111, 5411–5417 (2007).

    Article  CAS  Google Scholar 

  20. Lo Conte, L., Chothia, C. & Janin, J. The atomic structure of protein–protein recognition sites. J. Mol. Biol. 285, 2177–2198 (1999).

    Article  CAS  Google Scholar 

  21. Zhao, H. Effect of ions and other compatible solutes on enzyme activity, and its implication for biocatalysis using ionic liquids. J. Mol. Catal. B 37, 16–25 (2005).

    Article  CAS  Google Scholar 

  22. Ngo, T. T. & Narinesingh, D. Kosmotropes enhance the yield of antibody purified by affinity chromatography using immobilized bacterial immunoglobulin binding proteins. J. Immunoassay Immunochem. 29, 105–115 (2008).

    Article  CAS  Google Scholar 

  23. Schubert, U. S., Knop, K., Hoogenboom, R. & Fischer, D. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. 49, 6288–6308 (2010).

    Article  Google Scholar 

  24. Cao, Z. Q., Yu, Q. M., Xue, H., Cheng, G. & Jiang, S. Y. Nanoparticles for drug delivery prepared from amphiphilic PLGA zwitterionic block copolymers with sharp contrast in polarity between two blocks. Angew. Chem. Int. Ed. 49, 3771–3776 (2010).

    Article  CAS  Google Scholar 

Download references


This work was supported by the Office of Naval Research (N000140910137 and N000141010600) and the National Science Foundation (DMR-1005699). A.J.K. was partially supported through a National Cancer Institute training grant (T32CA138312). The authors thank the members of the Jiang research group, especially Zhiqiang Cao and Hong Xue, for helpful discussions.

Author information

Authors and Affiliations



A.J.K. performed all the experiments presented in this work. A.J.K. and S.J. designed the experiments and prepared the manuscript.

Corresponding author

Correspondence to Shaoyi Jiang.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information

Supplementary information (PDF 813 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keefe, A., Jiang, S. Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity. Nature Chem 4, 59–63 (2012).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research